2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee

Verger, Antoine; Barthel, Henryk; Tolboom, Nelleke; Fraioli, Francesco; Cecchin, Diego; Albert, Nathalie L.; van Berckel, Bart; Boellaard, Ronald; Brendel, Matthias; Ekmekcioglu, Ozgul; Semah, Franck; Traub-Weidinger, Tatjana; van de Weehaeghe, Donatienne; Morbelli, Silvia; Guedj, Eric

doi:https://doi.org/10.1007/s00259-022-05913-7

2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee

DSpace/Manakin Repository

2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee

Verger, Antoine; Barthel, Henryk; Tolboom, Nelleke; Fraioli, Francesco; Cecchin, Diego; Albert, Nathalie L.; van Berckel, Bart; Boellaard, Ronald; Brendel, Matthias; Ekmekcioglu, Ozgul; Semah, Franck; Traub-Weidinger, Tatjana; van de Weehaeghe, Donatienne; Morbelli, Silvia; Guedj, Eric

(2022) European Journal of Nuclear Medicine and Molecular Imaging, volume 49, issue 11, pp. 3599 - 3606

(Editorial)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Brain/diagnostic imaging, COVID-19/complications, Fluorodeoxyglucose F18, Humans, Neuroimaging, Positron-Emission Tomography/methods, Radiopharmaceuticals, Post-Acute COVID-19 Syndrome, Radiology Nuclear Medicine and imaging, Editorial

DOI: https://doi.org/10.1007/s00259-022-05913-7

ISSN: 1619-7070

Publisher: Springer-Verlag

(Peer reviewed)